Thus, loss of PTEN is likely an early event in endometrial tumorigenesis and likely initiated in response to known hormonal risk factors for endometrial cancer such as obesity and insulin resistance. The gene discussed is PTEN; the disease is obesity due to melanocortin 4 receptor deficiency.